Sir Michael Rawlins
And finally this week, Professor Sir Michael Rawlins has been appointed to the Board of Directors at Intra-Cellular Therapies.
Rawlins, a renowned figure in the field of drug safety, clinical effectiveness and cost effectiveness, has been Chairman of the UK's National Institute for Clinical Excellence (NICE) from 1999 (at its inception) through March 2013.
“We are excited to have Sir Michael Rawlins join our board,” said Dr. Sharon Mates, CEO of Intra-Cellular Therapies. “His expertise in the cost-effectiveness of new pharmaceuticals and other issues in health economics will be invaluable to Intra-Cellular Therapies. I look forward to working closely with Michael as we transition our clinical programs through late-stage development and commercial approval.”